These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25985992)

  • 1. Costs and cost-effectiveness of a large-scale mass testing and treatment intervention for malaria in Southern Province, Zambia.
    Silumbe K; Yukich JO; Hamainza B; Bennett A; Earle D; Kamuliwo M; Steketee RW; Eisele TP; Miller JM
    Malar J; 2015 May; 14():211. PubMed ID: 25985992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-wide malaria testing and treatment with rapid diagnostic tests and artemether-lumefantrine in southern Zambia: a community randomized step-wedge control trial design.
    Larsen DA; Bennett A; Silumbe K; Hamainza B; Yukich JO; Keating J; Littrell M; Miller JM; Steketee RW; Eisele TP
    Am J Trop Med Hyg; 2015 May; 92(5):913-921. PubMed ID: 25802434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia.
    Chanda P; Masiye F; Chitah BM; Sipilanyambe N; Hawela M; Banda P; Okorosobo T
    Malar J; 2007 Feb; 6():21. PubMed ID: 17313682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operational response to malaria epidemics: are rapid diagnostic tests cost-effective?
    Rolland E; Checchi F; Pinoges L; Balkan S; Guthmann JP; Guerin PJ
    Trop Med Int Health; 2006 Apr; 11(4):398-408. PubMed ID: 16553923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness study of three antimalarial drug combinations in Tanzania.
    Wiseman V; Kim M; Mutabingwa TK; Whitty CJ
    PLoS Med; 2006 Oct; 3(10):e373. PubMed ID: 17032059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community case management of fever due to malaria and pneumonia in children under five in Zambia: a cluster randomized controlled trial.
    Yeboah-Antwi K; Pilingana P; Macleod WB; Semrau K; Siazeele K; Kalesha P; Hamainza B; Seidenberg P; Mazimba A; Sabin L; Kamholz K; Thea DM; Hamer DH
    PLoS Med; 2010 Sep; 7(9):e1000340. PubMed ID: 20877714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deploying artemether-lumefantrine with rapid testing in Ethiopian communities: impact on malaria morbidity, mortality and healthcare resources.
    Lemma H; Byass P; Desta A; Bosman A; Costanzo G; Toma L; Fottrell E; Marrast AC; Ambachew Y; Getachew A; Mulure N; Morrone A; Bianchi A; Barnabas GA
    Trop Med Int Health; 2010 Feb; 15(2):241-50. PubMed ID: 19961564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved diagnostic testing and malaria treatment practices in Zambia.
    Hamer DH; Ndhlovu M; Zurovac D; Fox M; Yeboah-Antwi K; Chanda P; Sipilinyambe N; Simon JL; Snow RW
    JAMA; 2007 May; 297(20):2227-31. PubMed ID: 17519412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of Focal Mass Drug Administration and Mass Drug Administration with Dihydroartemisinin-Piperaquine for Malaria Prevention in Southern Province, Zambia: Results of a Community-Randomized Controlled Trial.
    Yukich JO; Scott C; Silumbe K; Larson BA; Bennett A; Finn TP; Hamainza B; Conner RO; Porter TR; Keating J; Steketee RW; Eisele TP; Miller JM
    Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):46-53. PubMed ID: 32618249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass testing and treatment for malaria followed by weekly fever screening, testing and treatment in Northern Senegal: feasibility, cost and impact.
    Conner RO; Dieye Y; Hainsworth M; Tall A; Cissé B; Faye F; Sy MD; Ba A; Sene D; Ba S; Doucouré E; Thiam T; Diop M; Schneider K; Cissé M; Ba M; Earle D; Guinot P; Steketee RW; Guinovart C
    Malar J; 2020 Jul; 19(1):252. PubMed ID: 32664939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study protocol for a cluster randomised controlled factorial design trial to assess the effectiveness and feasibility of reactive focal mass drug administration and vector control to reduce malaria transmission in the low endemic setting of Namibia.
    Medzihradsky OF; Kleinschmidt I; Mumbengegwi D; Roberts KW; McCreesh P; Dufour MK; Uusiku P; Katokele S; Bennett A; Smith J; Sturrock H; Prach LM; Ntuku H; Tambo M; Didier B; Greenhouse B; Gani Z; Aerts A; Gosling R; Hsiang MS
    BMJ Open; 2018 Jan; 8(1):e019294. PubMed ID: 29374672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of malaria microscopy and rapid diagnostic tests versus presumptive diagnosis: implications for malaria control in Uganda.
    Batwala V; Magnussen P; Hansen KS; Nuwaha F
    Malar J; 2011 Dec; 10():372. PubMed ID: 22182735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance and time to become negative after treatment of three malaria rapid diagnostic tests in low and high malaria transmission settings.
    Grandesso F; Nabasumba C; Nyehangane D; Page AL; Bastard M; De Smet M; Boum Y; Etard JF
    Malar J; 2016 Oct; 15(1):496. PubMed ID: 27716244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of an Intervention to Improve Malaria Care in Public Health Centers on Health Indicators of Children in Tororo, Uganda (PRIME): A Cluster-Randomized Trial.
    Staedke SG; Maiteki-Sebuguzi C; DiLiberto DD; Webb EL; Mugenyi L; Mbabazi E; Gonahasa S; Kigozi SP; Willey BA; Dorsey G; Kamya MR; Chandler CIR
    Am J Trop Med Hyg; 2016 Aug; 95(2):358-367. PubMed ID: 27273646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent preventive therapy for malaria with monthly artemether-lumefantrine for the post-discharge management of severe anaemia in children aged 4-59 months in southern Malawi: a multicentre, randomised, placebo-controlled trial.
    Phiri K; Esan M; van Hensbroek MB; Khairallah C; Faragher B; ter Kuile FO
    Lancet Infect Dis; 2012 Mar; 12(3):191-200. PubMed ID: 22172305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A qualitative study of perceptions of a mass test and treat campaign in Southern Zambia and potential barriers to effectiveness.
    Silumbe K; Chiyende E; Finn TP; Desmond M; Puta C; Hamainza B; Kamuliwo M; Larsen DA; Eisele TP; Miller J; Bennett A
    Malar J; 2015 Apr; 14():171. PubMed ID: 25896068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality and safety of integrated community case management of malaria using rapid diagnostic tests and pneumonia by community health workers.
    Hamer DH; Brooks ET; Semrau K; Pilingana P; MacLeod WB; Siazeele K; Sabin LL; Thea DM; Yeboah-Antwi K
    Pathog Glob Health; 2012 Mar; 106(1):32-9. PubMed ID: 22595272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the consent of the patients have a role to play in formulating a treatment policy?
    Kango M; Baboo KS
    Trop Doct; 2008 Jan; 38(1):56-7. PubMed ID: 18302874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria.
    Lubell Y; Hopkins H; Whitty CJ; Staedke SG; Mills A
    Malar J; 2008 Jan; 7():21. PubMed ID: 18226224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiological impact of HIV antiretroviral therapy on malaria in children.
    Greenhalgh S; Ndeffo M; Galvani AP; Parikh S
    AIDS; 2015 Feb; 29(4):473-82. PubMed ID: 25486414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.